IL6 and Cognitive impairment: A meta‐analysis reported that IL‐6 and sVCAM‐1 levels are higher in T2DM patients with cognitive impairment, indicating an increased inflammatory‐vascular interaction associated with cognitive dysfunction in T2DM (Anita et al.